Sotera Health (SHC) Projected to Post Earnings on Thursday

Sotera Health (NASDAQ:SHC) is expected to release its Q1 2025 earnings data before the market opens on Thursday, May 1st. Analysts expect Sotera Health to post earnings of $0.12 per share and revenue of $245.56 million for the quarter.

Sotera Health Stock Performance

NASDAQ:SHC opened at $11.31 on Wednesday. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The company has a 50 day moving average price of $11.47 and a 200 day moving average price of $13.10. Sotera Health has a fifty-two week low of $9.53 and a fifty-two week high of $17.08. The stock has a market capitalization of $3.21 billion, a P/E ratio of 45.24 and a beta of 1.88.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on SHC shares. Barclays cut their price objective on Sotera Health from $16.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, April 10th. Piper Sandler lowered their price objective on shares of Sotera Health from $15.00 to $13.00 and set a “neutral” rating for the company in a research note on Wednesday, April 23rd. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $15.20.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.